Skip to main content
. 2020 Jun 10;12(6):1519. doi: 10.3390/cancers12061519

Figure 6.

Figure 6

Figure 6

Schematic representation of molecular pathways involved in response to pazopanib and trametinib treatment (A), Activated pathways in osteosarcoma cell lines (B), Modulation of pathways upon pazopanib and trametinib treatment.